Total-body PET scanner detects cancer in 60 seconds

One of the only total-body PET scanners in the United States arrived at its new home in Grand Rapids, Michigan, this week. 

The machine, which can image patients from head to toe in one pass, is located at Michigan State University, the university announced May 9. Unlike conventional PET scans that take anywhere from 20 to 45 minutes to complete, the new MSU scanner can conduct total body scans in as little as 60 seconds.  

Imaging is completed quickly, and providers gain the ability to begin treating a patient’s cancer on the same day, likely within hours of their diagnosis, doctors with Bold Advanced Medical Future (BAMF) Health told news crews at an unveiling of the scanner. This is because of the scanner’s placement in the same building as the university’s radiopharmacy. 

"It's a very precise, targeted, specific type of cancer treatment, as opposed to some of the more general cancer care that we're used to," Dr. Brandon Mancini, medical director for BAMF Health, shared with news crews. "We're going to be able to produce radiotracers that have not been able to be used clinically, and again, impact more people more quickly." 

The new technology comes as a result of a generous $19.5 million grant that Doug Meijer gave to Michigan State University. Meijer’s own stage 4 prostate cancer diagnosis served as the inspiration behind the project, as he has personal experience undergoing exams using scanner in Germany. 

The new equipment, which initially will reserved for patients with prostate and neuroendocrine tumors, is expected to be operational in July. BAMF Health is said to be working with insurers to obtain coverage for the imaging and treatments. 

Related PET imaging news: 

FDG PET/CT radiomics distinguishes between vaccine-related or metastatic breast cancer lymphadenopathy

Combination therapy that includes new radionuclide proves effective for metastatic prostate cancer

New radiotracer that detects prostate cancer recurrence produces 'stunning' results

'Pandemic brain': PET/MRI images reveal how COVID's impact is felt by non-infected individuals

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She began covering the medical imaging industry for Innovate Healthcare in 2021.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.